Lassa virus (Q35919691)

11 August 2017

1 reference

title

Lassa virus (English)

1 reference

11 August 2017

0 references

1

Stephan Günther

0 references

author name string

Oliver Lenz

series ordinal

2

1 reference

11 August 2017

publication date

1 January 2004

1 reference

Critical Reviews in Clinical Laboratory Sciences

11 August 2017

published in

1 reference

11 August 2017

volume

41

1 reference

11 August 2017

issue

4

1 reference

11 August 2017

page(s)

339-390

1 reference

Sequence analysis of L RNA of Lassa virus

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Arenaviruses other than Lassa virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Interrelationships Among Arenaviruses Measured by Indirect Immunofluorescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Phylogenetic Analysis of theArenaviridae:Patterns of Virus Evolution and Evidence for Cospeciation between Arenaviruses and Their Rodent Hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Genetic diversity among Lassa virus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Evolution of the Old World Arenaviridae and their rodent hosts: generalized host-transfer or association by descent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Protective Efficacy of a Live Attenuated Vaccine against Argentine Hemorrhagic Fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Lymphocytic choriomeningitis virus in southern France: four case reports and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Lymphocytic choriomeningitis virus: an unrecognized teratogenic pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Congenital lymphocytic choriomeningitis virus infection: decade of rediscovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Congenital lymphocytic choriomeningitis virus syndrome: a disease that mimics congenital toxoplasmosis or Cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Congenital lymphocytic choriomeningitis virus infection: an underdiagnosed disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Lymphocytic choriomeningitis virus: reemerging central nervous system pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Lymphocytic choriomeningitis virus: an underdiagnosed cause of congenital chorioretinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Ribonucleic acids of Machupo and Lassa viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Immunological identification of Tacaribe virus proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Sequence analysis of the S RNA of the African arenavirus Mopeia: an unusual secondary structure feature in the intergenic region

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Nucleotide sequence of the S RNA of Lassa virus (Nigerian strain) and comparative analysis of arenavirus gene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Nucleotide sequence of the Lassa virus (Josiah strain) S genome RNA and amino acid sequence comparison of the N and GPC proteins to other arenaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Nucleotide sequence of the glycoprotein gene and intergenic region of the Lassa virus S genome RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Molecular cloning of Lassa virus RNA: nucleotide sequence and expression of the nucleocapsid protein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Complete sequence of the S RNA of lymphocytic choriomeningitis virus (WE strain) compared to that of Pichinde arenavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Molecular characterization of the genomic S RNA segment from lymphocytic choriomeningitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

The primary structure of the lymphocytic choriomeningitis virus L gene encodes a putative RNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Analysis of the genomic L RNA segment from lymphocytic choriomeningitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

The Lassa fever virus L gene: nucleotide sequence, comparison, and precipitation of a predicted 250 kDa protein with monospecific antiserum

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Completion of the Lassa Fever Virus Sequence and Identification of a RING Finger Open Reading Frame at the L RNA 5′ End

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Sequence comparison of the large genomic RNA segments of two strains of lymphocytic choriomeningitis virus differing in pathogenic potential for guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

The completed sequence of lymphocytic choriomeningitis virus reveals a unique RNA structure and a gene for a zinc finger protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Characterization of the genomic promoter of the prototypic arenavirus lymphocytic choriomeningitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Fine structure analysis of Pichinde virus nucleocapsids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

RING finger Z protein of lymphocytic choriomeningitis virus (LCMV) inhibits transcription and RNA replication of an LCMV S-segment minigenome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

The 3' end termini of the Tacaribe arenavirus subgenomic RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Transcription and RNA replication of tacaribe virus genome and antigenome analogs require N and L proteins: Z protein is an inhibitor of these processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Nontemplated bases at the 5' ends of Tacaribe virus mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Prevention of virus-induced cerebellar diseases by defective-interfering lymphocytic choriomeningitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Identification of MaTu-MX agent as a new strain of lymphocytic choriomeningitis virus (LCMV) and serological indication of horizontal spread of LCMV in human population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

MENINGITIS IN MAN CAUSED BY A FILTERABLE VIRUS : I. TWO CASES AND THE METHOD OF OBTAINING A VIRUS FROM THEIR SPINAL FLUIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Susceptibility and Resistance of Inbred Strains of Syrian Golden Hamsters (Mesocricetus auratus) to Wasting Disease Caused by Lymphocytic Choriomeningitis Virus: Pathogenesis of Lethal and Non-lethal Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Arenavirus-mediated liver pathology: acute lymphocytic choriomeningitis virus infection of rhesus macaques is characterized by high-level interleukin-6 expression and hepatocyte proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Standardization of a plaque assay for Lassa virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Persistence of lymphocytic choriomeningitis virus at very low levels in immune mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Reassortant analysis of guinea pig virulence of pichinde virus variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Generation of reassortants between African arenaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Organ-specific selection of viral variants during chronic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Viral escape from the neutralizing antibody response: the lymphocytic choriomeningitis virus model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Viral persistence in vivo through selection of neutralizing antibody-escape variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

In vitro selection of Junin virus antigenic variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Properties and characterization of monoclonal antibodies to Tacaribe virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

CD4 T-cell-epitope escape mutant virus selected in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

In vitro selection of lymphocytic choriomeningitis virus escape mutants by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Role of the virus nucleoprotein in the regulation of lymphocytic choriomeningitis virus transcription and RNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Biochemical and immunological evidence that the 11 kDa zinc-binding protein of lymphocytic choriomeningitis virus is a structural component of the virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Zinc-binding properties of Junín virus nucleocapsid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Cells expressing the RING finger Z protein are resistant to arenavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Characterization of the arenavirus RING finger Z protein regions required for Z-mediated inhibition of viral RNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Tacaribe virus Z protein interacts with the L polymerase protein to inhibit viral RNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Characterization of the Lassa virus matrix protein Z: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

The small RING finger protein Z drives arenavirus budding: Implications for antiviral strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Nuclear dots: Actors on Many Stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Effects of promyelocytic leukemia protein on virus-host balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

The lymphocytic choriomeningitis virus RING protein Z associates with eukaryotic initiation factor 4E and selectively represses translation in a RING-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

The RING domains of the promyelocytic leukemia protein PML and the arenaviral protein Z repress translation by directly inhibiting translation initiation factor eIF4E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Self-assembly properties of a model RING domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Signal peptide of Lassa virus glycoprotein GP-C exhibits an unusual length

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Long-lived signal peptide of lymphocytic choriomeningitis virus glycoprotein pGP-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Identification of Lassa virus glycoprotein signal peptide as a trans-acting maturation factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Post-translational processing of the glycoproteins of lymphocytic choriomeningitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase SKI-1/S1P.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Identification of a novel consensus sequence at the cleavage site of the Lassa virus glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Mechanisms for lymphocytic choriomeningitis virus glycoprotein cleavage, transport, and incorporation into virions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Crimean-Congo hemorrhagic fever virus glycoprotein proteolytic processing by subtilase SKI-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Protein-protein interactions in lymphocytic choriomeningitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

The viral transmembrane superfamily: possible divergence of Arenavirus and Filovirus glycoproteins from a common RNA virus ancestor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

The fusion of artificial lipid membranes induced by the synthetic arenavirus 'fusion peptide'

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Prediction of arenavirus fusion peptides on the basis of computer analysis of envelope protein sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Kinetics and pH dependence of acid-induced structural changes in the lymphocytic choriomeningitis virus glycoprotein complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Mechanism of lymphocytic choriomeningitis virus entry into cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Acidic pH triggers LCMV membrane fusion activity and conformational change in the glycoprotein spike

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Early events in arenavirus replication are sensitive to lysosomotropic compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Alpha-dystroglycan can mediate arenavirus infection in the absence of beta-dystroglycan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Differences in affinity of binding of lymphocytic choriomeningitis virus strains to the cellular receptor alpha-dystroglycan correlate with viral tropism and disease kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

New World arenavirus clade C, but not clade A and B viruses, utilizes alpha-dystroglycan as its major receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Distribution of dystroglycan in normal adult mouse tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Molecular analysis of the interaction of LCMV with its cellular receptor [alpha]-dystroglycan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Isolation and Antigenic Characterization of Lassa Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

A prospective study of the epidemiology and ecology of Lassa fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Lassa virus activity in Guinea: distribution of human antiviral antibody defined using enzyme-linked immunosorbent assay with recombinant antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Lassa fever in Guinea: I. Epidemiology of human disease and clinical observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Endemic Lassa fever in Liberia. VI. Village serological surveys for evidence of Lassa virus activity in Lofa County, Liberia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Endemic Lassa fever in Liberia. II. Serological and virological findings in hospital patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Endemic Lassa fever in Liberia. V. Distribution of Lassa virus activity in Liberia: hospital staff surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Endemic Lassa fever in Liberia. I. Clinical and epidemiological aspects at Curran Lutheran Hospital, Zorzor, Liberia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

A survey for antibodies to Lassa virus among health workers in Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Lassa fever Epidemiological aspects of the 1970 epidemic, Jos, Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Lassa fever A study of 23 hospital cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Imported lassa fever in Germany: molecular characterization of a new lassa virus strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Lassa fever in Guinea: II. Distribution and prevalence of Lassa virus infection in small mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Hemorrhagic fever occurs after intravenous, but not after intragastric, inoculation of rhesus macaques with lymphocytic choriomeningitis virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Effect of environmental factors on aerosol-induced Lassa virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

A case-control study of the clinical diagnosis and course of Lassa fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Antibodies to Lassa virus Z protein and nucleoprotein co-occur in human sera from Lassa fever endemic regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Comparison of Lassa, Mobala, and Ippy virus reactions by immunofluorescence test

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Identification of Ippy as a Lassa-fever-related virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Safe intensive-care management of a severe case of Lassa fever with simple barrier nursing techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

No evidence for increased risk of Lassa fever infection in hospital staff

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Short communication: Lassa fever in Sierra Leone: UN peacekeepers are at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Endemic Lassa fever in Liberia. III. Characterization of Lassa virus isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Endemic Lassa fever in Liberia. IV. Selection of optimally effective plasma for treatment by passive immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

High genetic divergence and recombination in Arenaviruses from the Americas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Lassa fever encephalopathy: Lassa virus in cerebrospinal fluid but not in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

The Whitewater Arroyo virus: natural evidence for genetic recombination among Tacaribe serocomplex viruses (family Arenaviridae).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

The pathology of Lassa fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Experimental Infection of Rhesus Monkeys with Lassa Virus and a Closely Related Arenavirus, Mozambique Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Physiological and immunologic disturbances associated with shock in a primate model of Lassa fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Hematologic dysfunction in Lassa fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Plasma from patients with severe Lassa fever profoundly modulates f-met-leu-phe induced superoxide generation in neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

A plasma inhibitor of platelet aggregation in patients with Lassa fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Clinical virology of Lassa fever in hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Monitoring of clinical and laboratory data in two cases of imported Lassa fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Reversal of virus-induced systemic shock and respiratory failure by blockade of the lymphotoxin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Immune serum increases arenavirus replication in monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Mucosal arenavirus infection of primates can protect them from lethal hemorrhagic fever.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Lethal H5N1 influenza viruses escape host anti-viral cytokine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Baculovirus expression of the glycoprotein gene of Lassa virus and characterization of the recombinant protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Identification of Lassa fever virus infection with recombinant nucleocapsid protein antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Epitope mapping of the Lassa virus nucleoprotein using monoclonal anti-nucleocapsid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Lassa virus glycoproteins: antigenic and immunogenic properties of synthetic peptides to GP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Fine mapping of a peptide sequence containing an antigenic site conserved among arenaviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Characterization of human CD4( ) T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Long-lived memory T lymphocyte responses after hantavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Effective vaccine for lassa fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

A non-retroviral RNA virus persists in DNA form

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

A case of Lassa fever: clinical and virological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Lassa fever in children in Sierra Leone, West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Lassa fever. Effective therapy with ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Acute sensorineural deafness in Lassa fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

An imported case of Lassa fever with late appearance of polyserositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Imported Lassa fever--reexamining the algorithms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Lassa fever in the United States. Investigation of a case and new guidelines for management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Lassa fever: response to an imported case

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Lassa fever in Britain: an imported case

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Imported Lassa fever in Germany: surveillance and management of contact persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Enhanced treatment of Lassa fever by immune plasma combined with ribavirin in cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Unexpected adverse reactions during a clinical trial in rural west Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Prospective, Double-Blind, Concurrent, Placebo-Controlled Clinical Trial of Intravenous Ribavirin Therapy of Hemorrhagic Fever with Renal Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Common Adverse Events Associated with the Use of Ribavirin for Severe Acute Respiratory Syndrome in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Lassa fever virological and serological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Use of monoclonal antibody for the detection of Lassa virus antibody and antigen in patients with Lassa fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Early diagnosis of human Lassa fever by ELISA detection of antigen and antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Molecular diagnostics of viral hemorrhagic fevers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Effects of primer-template mismatches on the polymerase chain reaction: human immunodeficiency virus type 1 model studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

The effects of internal primer-template mismatches on RT-PCR: HIV-1 model studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Sequence comparison of five polymerases (L proteins) of unsegmented negative-strand RNA viruses: theoretical assignment of functional domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Characterization of arenaviruses using a family-specific primer set for RT-PCR amplification and RFLP analysis. Its potential use for detection of uncharacterized arenaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

False-Negative Results of PCR Assay with Plasma of Patients with Severe Viral Hemorrhagic Fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Expression of Lassa virus nucleocapsid protein segments in bacteria: purification of high-level expression products and their application in antibody detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Expression of the Lassa virus nucleocapsid protein in insect cells infected with a recombinant baculovirus: application to diagnostic assays for Lassa virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Synergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses, and arenaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

A newly developed immunofluorescent assay for determining the Pichinde virus-inhibitory effects of selected nucleoside analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Inhibitory effect of selected antiviral compounds on arenavirus replication in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

New hypoxanthine nucleosides with RNA antiviral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Selective inhibition of arthropod-borne and arenaviruses in vitro by 3'-fluoro-3'-deoxyadenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Molecular approaches for the treatment of hemorrhagic fever virus infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Inhibition of arenavirus multiplication in vitro by phenotiazines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Antiviral and virucidal activities against arenaviruses of zinc-finger active compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Antiviral effect of brassinosteroids against herpes virus and arenaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Effect of fatty acids on arenavirus replication: inhibition of virus production by lauric acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Experimental Lassa fever virus infection successfully treated with ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

RNA virus error catastrophe: direct molecular test by using ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Molecular indetermination in the transition to error catastrophe: systematic elimination of lymphocytic choriomeningitis virus through mutagenesis does not correlate linearly with large increases in mutant spectrum complexity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Protection of Lassa virus-infected guinea pigs with Lassa-immune plasma of guinea pig, primate, and human origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

The use of Lassa fever convalescent plasma in Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Experimental study on the possibility of treatment of some hemorrhagic fevers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Arenavirus infection in the guinea pig model: antiviral therapy with recombinant interferon-alpha, the immunomodulator CL246,738 and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Towards a human Lassa fever vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guineapigs against Lassa fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Construction of a recombinant vaccinia virus expressing the Lassa virus glycoprotein gene and protection of guinea pigs from a lethal Lassa virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Inactivated Lassa virus elicits a non protective immune response in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Protection of rhesus monkeys from Lassa virus by immunisation with closely related Arenavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

Murine immune responses to mucosally delivered Salmonella expressing Lassa fever virus nucleoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10408360490497456

10.1080/10408360490497456

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference